National Institutes of Health

NIH-funded trial launched to assess experimental TB drug

A clinical trial will examine an investigational drug’s (AZD5847) early bacteria-killing activity in patients newly diagnosed with drug-sensitive pulmonary tuberculosis, including individuals who are also infected with HIV but not yet taking antiretroviral treatmen.

Read More →

NIAID statement on World TB Day - March 24, 2012

Christine F. Sizemore, Ph.D., Richard E. Hafner, M.D., and Anthony S. Fauci, M.D., National Institute of Allergy and Infectious Diseases, National Institutes of Health

Read More →

Page 1 of 1 · Total posts: 2